Related Experiment Videos
Monoclonal antibody to human granulocytes: cellular specificity and functional studies
Journal of Leukocyte Biology
|March 1, 1984
Summary
The G2 monoclonal antibody specifically targets human granulocytes and inhibits their functional responses. This antibody is a valuable tool for studying granulocyte activation and related cell surface antigens.
Area of Science:
- Immunology
- Cell Biology
Background:
- Monoclonal antibodies are crucial tools for identifying cell surface antigens.
- Understanding granulocyte function is vital in immunology and disease research.
Purpose of the Study:
- To characterize the antigenic specificity and functional effects of the G2 monoclonal antibody against human granulocytes.
- To explore the potential of G2 in elucidating granulocyte activation mechanisms.
Main Methods:
- Production of G2 monoclonal antibody using hybridoma technology (Balb/c mice spleen cells fused with SP2/0 myeloma).
- Testing G2 reactivity against various human cell lines (HL60, K562), peripheral blood cells (granulocytes, lymphocytes, erythrocytes), and leukemia cell lines (ALL, CLL, AML).
- Assessing G2's functional impact on human polymorphonuclear leukocytes (PMNL) responses to stimuli like aggregated IgG, zymosan, FMLP, A23187, and PMA.
Main Results:
- G2 demonstrated specific reactivity with human granulocytes, HL60, and K562 cell lines.
- G2 showed reactivity with cell surface antigens in acute myelomonocytic leukemia and some cases of acute undifferentiated leukemia.
- G2 inhibited PMNL oxygen consumption induced by various stimuli, with dose-dependent inhibition for PMA and digitonin.
Conclusions:
- The G2 monoclonal antibody exhibits specific reactivity towards human granulocytes and certain leukemia cell types.
- G2 effectively inhibits key functional responses of human polymorphonuclear leukocytes.
- G2 serves as a valuable reagent for investigating granulocyte membrane perturbation and activation pathways through specific antigen interactions.